Kytopen unveils Flowfect Discover platform for cell therapy development
Flowfect Discover is an automated high-throughput gene delivery platform designed to discover and optimise cell therapy and living…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 May 23
Flowfect Discover is an automated high-throughput gene delivery platform designed to discover and optimise cell therapy and living…
25 May 23
Technology provides groundbreaking planning and guidance capabilities
25 May 23
$2.4M contract from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Tech program supports clinical…
24 May 23
The T2Biothreat Panel is said to be a fully automated, direct-from-blood test designed to detect six biothreat pathogens…
24 May 23
Wear a continuous glucose monitor (CGM) once, and January will continue to provide glucose estimates, predictions, and insights…
23 May 23
The deal gives the US-based firm access to Oncimmune’s commercialised CE-IVD marked EarlyCDT Lung blood test, autoantibody platform,…
23 May 23
PRIME MDx allows users to process a range of sample types thanks to the clever adoption of pre-filled…
23 May 23
LEADOPTIK is developing a miniaturized imaging system ushering in a new level of real-time imaging deep inside human…
22 May 23
The Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is a molecular diagnostic test that detects and differentiates four of the…
19 May 23
The BD FACSDiscover S8 Cell Sorter is the first BD instrument to feature BD SpectralFX™ Technology and BD…